Chemoinformaics analysis of 14-DEOXY-11-OXOANDROGRAPHOLIDE
| Molecular Weight | 348.439 | nRot | 4 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 17 |
| Exact Molecular Weight | 348.194 | nRing | 3 |
| Solubility: LogS | -3.736 | nHRing | 1 |
| Solubility: LogP | 1.992 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 56.0802 |
| nHD | 2 | BPOL | 31.5618 |
| QED | 0.778 |
| Synth | 4.42 |
| Natural Product Likeliness | 1.767 |
| NR-PPAR-gamma | 0.527 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.147 |
| Pgp-sub | 0.111 |
| HIA | 0.134 |
| CACO-2 | -5.148 |
| MDCK | 0.0000123 |
| BBB | 0.34 |
| PPB | 0.927776 |
| VDSS | 0.974 |
| FU | 0.0792677 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.299 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.641 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.273 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.327 |
| CL | 16.588 |
| T12 | 0.845 |
| hERG | 0.008 |
| Ames | 0.019 |
| ROA | 0.378 |
| SkinSen | 0.162 |
| Carcinogencity | 0.527 |
| EI | 0.018 |
| Respiratory | 0.916 |
| NR-Aromatase | 0.446 |
| Antiviral | Yes |
| Prediction | 0.675011 |